MyFinsight
Home
Blog
About
Contact
Marketable securities
$196,560K
Cash and cash
equivalents
$65,665K
Trade accounts
receivable, net
$51,903K
Inventories
$49,791K
Prepaid expenses and
other current assets
$15,383K
Total current assets
$379,302K
Property and equipment,
net
$20,469K
Goodwill
$16,689K
Intangible assets, net
$15,704K
Operating lease
right-of-use assets
$10,643K
Other noncurrent
assets
$6,306K
Total assets
$449,113K
Total liabilities and
stockholders equity
$449,113K
Total stockholders
equity
$327,644K
Total liabilities
$121,469K
Accumulated deficit
-$120,604K
Additional paid-in capital
$445,750K
Total current
liabilities
$80,935K
Deferred revenue,
noncurrent
$17,672K
Operating lease
liability, noncurrent
$13,441K
Legal settlement
liability, noncurrent
$6,637K
Other noncurrent
liabilities
$2,398K
Long-term debt
$386K
Accumulated other
comprehensive gain
$2,369K
Common stock, 0.001 par
value 1,000,000,000...
$129K
Deferred revenue,
current
$30,032K
Other current
liabilities
$22,173K
Accrued expenses
$19,781K
Trade accounts
payable
$6,741K
Legal settlement
liability, current
$2,208K
Back
Back
Balance Sheet
Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB)
source: myfinsight.com